The biotechnology company posted revenue of $218.4 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks ...
News
- Seattle Genetics: 2Q Earnings Snapshot
- Idorsia: A Swiss Biotech Poised For Fantastic Growth
With this article, I wish to introduce my readers to a biotech with only a ... But at the end, I think you will agree - Idorsia (OTCPK:IDRSF) is a biotech with a .... Phase 2 data on 360 patients at the SLEEP conference held in San Antonio.
- Krishnan Suthanthiran, President & Founder of TeamBest Companies & Best Cure Foundation ...
SAN ANTONIO & WASHINGTON--(BUSINESS WIRE)--Jul 15, 2019-- ... OTHER NATURAL RESOURCES BIOTECHNOLOGY HEALTH NATURAL ...
- US stocks drift sideways as curtain rises for earning season
SLOW AND STEADY: European biotech company Galapagos's U.S.-listed shares surged 17.6% after Gilead Sciences invested $5 billion in it.
- Celcuity Inc. (CELC) EPS Estimated At $-0.20
... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... Bizjournals.com and their article: “Biotech startup Celcuity raises $23M in IPO – Minneapolis / St. Paul Business ...